---
figid: PMC10898200__IID3-12-e1195-g002
figtitle: OA inhibition by BDMC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10898200
filename: IID3-12-e1195-g002.jpg
figlink: /pmc/articles/PMC10898200/figure/F4
number: F4
caption: Schematic representation of OA inhibition by BDMC. BDMC inhibits the pyroptosis
  pathway by activating the Nrf2/HO‐1 signaling pathway, which exerts an effect on
  the degradation of cartilage ECM. BDMC, Bisdemethoxycurcumin; ECM, extracellular
  matrix; OA, osteoarthritis
papertitle: Bisdemethoxycurcumin, a curcumin, protects chondrocytes, and reduces cartilage
  inflammation via the NRF2/HO‐1/NLRP3 pathway
reftext: Gang Jin, et al. Immun Inflamm Dis. 2024 Feb;12(2).
year: '2024'
doi: 10.1002/iid3.1195
journal_title: Immunity, Inflammation and Disease
journal_nlm_ta: Immun Inflamm Dis
publisher_name: John Wiley and Sons Inc.
keywords: bisdemethoxycurcumin | cartilage | Nrf2 | osteoarthritis | pyroptosis
automl_pathway: 0.9571396
figid_alias: PMC10898200__F4
figtype: Figure
redirect_from: /figures/PMC10898200__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10898200__IID3-12-e1195-g002.html
  '@type': Dataset
  description: Schematic representation of OA inhibition by BDMC. BDMC inhibits the
    pyroptosis pathway by activating the Nrf2/HO‐1 signaling pathway, which exerts
    an effect on the degradation of cartilage ECM. BDMC, Bisdemethoxycurcumin; ECM,
    extracellular matrix; OA, osteoarthritis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GABPA
  - NFE2L2
  - NLRP3
  - HMOX1
  - GSDMD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - IL1A
  - IL1B
---
